Using evidence-based practice to reduce central line infections.
Brungs
Suzanne M
SM
Veterans Affairs Inpatient Evaluation Center, Cincinnati VA Medical Center, Ohio, USA. suzanne.brungs@va.gov
Render
Marta L
ML
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002423:Cause of Death; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D002985:Clinical Protocols; D017281:Cost of Illness; D003428:Cross Infection / Q000191:economics / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D004866:Equipment Contamination / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006787:Hospitals, Veterans; D006801:Humans; D017053:Infection Control / Q000379:methods* / Q000592:standards; D009820:Ohio / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D017751:Safety Management; D017592:Skin Care / Q000379:methods / Q000592:standards; D017749:Total Quality Management / Q000458:organization & administration; D016635:Universal Precautions
D000891:Anti-Infective Agents, Local; C010882:chlorhexidine gluconate; D002710:Chlorhexidine